| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| iti-007 | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Sleeplessness[MeSHID:D007319] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] Major Depressive Disorder[MeSHID:D003865] Schizophrenia[MeSHID:D012559] |
0.44 | phase 3 | unknown |
| iti-007 | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Sleeplessness[MeSHID:D007319] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] Major Depressive Disorder[MeSHID:D003865] Schizophrenia[MeSHID:D012559] |
0.44 | phase 3 | antagonist |
| iti-007 | serotonin transporter | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Sleeplessness[MeSHID:D007319] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] Major Depressive Disorder[MeSHID:D003865] Schizophrenia[MeSHID:D012559] |
0.65 | phase 3 | unknown |
| click here to return to the previous page | ||||||||